Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · Real-Time Price · USD

64.45

-0.11 (-0.16%)

At close: May 28, 2026, 4:00 PM EDT

64.43

-0.01 (-0.02%)

After-hours: May 28, 2026, 4:10 PM EDT

Monopar Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	432	437	134	5	31	40
Market Cap Growth	101.12%	225.50%	2549.34%	-83.48%	-24.13%	-42.31%
Enterprise Value	301.31	296.75	74.04	-2.2	17.57	20.14
Last Close Price	64.44	65.30	22.00	1.70	11.85	16.05
PB Ratio	3.19	3.17	2.44	0.91	3.04	2.14
P/TBV Ratio	3.71	3.51	1.52	0.84	2.99	2.11
EV/EBITDA Ratio	-	-	-	0.25	-	-
EV/EBIT Ratio	-	-	-	0.25	-	-
EV/FCF Ratio	-	-	-	0.28	-	-
Debt / Equity Ratio	0.00	0.00	0	0	0.00	0
Net Debt / Equity Ratio	-1.01	-1.02	-1.09	-1.30	-1.30	-1.07
Net Debt / EBITDA Ratio	7.34	8.40	3.73	0.82	1.24	2.23
Net Debt / FCF Ratio	13.72	11.49	9.40	0.93	1.81	2.78
Quick Ratio	55.94	51.33	11.46	4.13	4.19	12.85
Current Ratio	56.04	51.35	11.47	4.17	4.21	12.98
Return on Equity (ROE)	-10.97%	-14.22%	-51.42%	-107.19%	-72.44%	-52.57%
Return on Assets (ROA)	-13.43%	-16.62%	-47.79%	-85.86%	-62.44%	-48.82%
Return on Invested Capital (ROIC)	853.55%	440.05%	471.62%	375.80%	480.64%	758.10%
Return on Capital Employed (ROCE)	-13.68%	-17.31%	-53.32%	-112.60%	-72.57%	-52.71%
Buyback Yield / Dilution	-64.59%	-95.53%	-37.08%	-8.70%	-1.98%	-13.81%
Total Shareholder Return	-64.59%	-95.53%	-37.08%	-8.70%	-1.98%	-13.81%

Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q